Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients

Clinical trial NCT00563173 · UNKNOWN

Trial details

NCT number: NCT00563173
Sponsor: Tripep AB
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C Virus Infection

Start date: 2007-10-01
Primary completion: 2010-04-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.